We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.56B
AUM Growth
-$316M
Cap. Flow
-$742M
Cap. Flow %
-16.27%
Top 10 Hldgs %
15.49%
Holding
2,634
New
531
Increased
353
Reduced
471
Closed
900

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 9.63%
3 Financials 7.8%
4 Industrials 6.22%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
1676
Automatic Data Processing
ADP
$106B
-1,463
Closed -$315K
ADSK icon
1677
CALL
Autodesk
ADSK
$49.5B
-23,000
Closed -$4.79M
AEE icon
1678
Ameren
AEE
$30.3B
-2,574
Closed -$222K
AEHR icon
1679
Aehr Test Systems
AEHR
$2.61B
-33,396
Closed -$1.04M
AEON icon
1680
AEON Biopharma
AEON
$12.9M
-983
Closed -$718K
AEO icon
1681
American Eagle Outfitters
AEO
$2.88B
-41,669
Closed -$560K
AEP icon
1682
American Electric Power
AEP
$69.6B
-4,284
Closed -$390K
AERT
1683
Aeries Technology
AERT
$35.2M
-26,057
Closed -$2.16M
AFL icon
1684
Aflac
AFL
$64.9B
-3,703
Closed -$239K
AGI icon
1685
Alamos Gold
AGI
$11.6B
-12,367
Closed -$151K
AI icon
1686
CALL
C3.ai
AI
$1.43B
-27,000
Closed -$906K
AIN icon
1687
Albany International
AIN
$2.11B
-3,460
Closed -$309K
AJG icon
1688
Arthur J. Gallagher & Co
AJG
$64.1B
-19,900
Closed -$3.81M
AKRO
1689
DELISTED
Akero Therapeutics
AKRO
-10,035
Closed -$384K
ALDX icon
1690
Aldeyra Therapeutics
ALDX
$92.9M
-16,521
Closed -$164K
ALGM icon
1691
Allegro MicroSystems
ALGM
$7.73B
-4,766
Closed -$229K
ALGN icon
1692
CALL
Align Technology
ALGN
$12.1B
-6,000
Closed -$2M
ALIT icon
1693
Alight
ALIT
$447M
-1,392
Closed -$256K
ALK icon
1694
Alaska Air
ALK
$5.29B
-13,154
Closed -$552K
ALKT icon
1695
Alkami Technology
ALKT
$1.94B
-11,601
Closed -$147K
ALLY icon
1696
PUT
Ally Financial
ALLY
$13.2B
-20,700
Closed -$528K
ALSN icon
1697
Allison Transmission
ALSN
$9.5B
-5,094
Closed -$230K
ALT icon
1698
CALL
Altimmune
ALT
$552M
-221,500
Closed -$935K
ALT icon
1699
Altimmune
ALT
$552M
-175,860
Closed -$742K
ALT icon
1700
PUT
Altimmune
ALT
$552M
-256,400
Closed -$1.08M

Similar funds

Boothbay Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boothbay Fund Management held 2,634 positions worth $4.56B, down 6.5% from $4.87B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $742M in Q2 2023, closing 900 positions and reducing 471 holdings. Its most notable exit was Alternus Clean Energy Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Boothbay Fund Management opened a new position in Indivior Pharmaceuticals worth $21.9M.

  • Boothbay Fund Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 946,208 shares worth $21.9M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $26.9M increase.
  • Boothbay Fund Management's biggest Q2 2023 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $23.1M.
  • Boothbay Fund Management fully exited Alternus Clean Energy Inc in Q2 2023, selling an estimated $12.1M.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $4.56B portfolio in Q2 2023.
  • Boothbay Fund Management opened 531 new positions and closed 900 in Q2 2023.
  • Boothbay Fund Management's portfolio value fell 6.5% quarter-over-quarter to $4.56B.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.